Reduced quality of in-vitro clot formation with gelatin-based plasma substitutes.
Mardel
S N
SN
Saunders
F
F
Ollerenshaw
L
L
Edwards
C
C
Baddeley
D
D
D001777:Blood Coagulation / Q000187:drug effects*; D005780:Gelatin / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007552:Isotonic Solutions / Q000494:pharmacology; D008855:Microscopy, Electron, Scanning; D010952:Plasma Substitutes / Q000494:pharmacology*; D011097:Polygeline / Q000494:pharmacology; D000077325:Ringer's Lactate; D013386:Succinates / Q000494:pharmacology; D013916:Thrombelastography
D007552:Isotonic Solutions; D010952:Plasma Substitutes; D000077325:Ringer's Lactate; D013386:Succinates; C060085:succinylated gelatin; D005780:Gelatin; D011097:Polygeline